Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting NeuropathyMaría Apellániz-Ruiz, Cristina Rodríguez‐Antona, Beatriz Castelo et al.|Clinical Cancer Research|2014Cited by 72
Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast CancerZhen Shi, Steven J. Isakoff, Julia Wulfkuhle et al.|Clinical Cancer Research|2021Cited by 54
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral NeuropathyLara M. Munín Sánchez, Cristina Rodríguez‐Antona, María Apellániz-Ruiz et al.|The Oncologist|2018Cited by 37
Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral NeuropathyMaría Apellániz-Ruiz, Cristina Rodríguez‐Antona, Héctor Tejero et al.|Clinical Cancer Research|2016Cited by 22